Maxime Schvartz

Follow

Generating author description...

Common Coauthors
Commonly Cited References
Action Title Year Authors # of times referenced
+ PDF Chat The control of the false discovery rate in multiple testing under dependency 2001 Yoav Benjamini
Daniel Yekutieli
1
+ PDF Chat Dynamics of Ebola RNA Persistence in Semen: A Report From the Postebogui Cohort in Guinea 2017 Fabien Subtil
Charlotte Lanièce Delaunay
Alpha Kabinet Keïta
Mamadou Sow
Abdoulaye Touré
Sandrine Leroy
Philippe Msellati
N’Fally Magassouba
Sylvain Baize
Hervé Raoul
1
+ Correlates of vaccine-induced protective immunity against Ebola virus disease 2018 Donata Medaglini
Francesco Santoro
Claire‐Anne Siegrist
1
+ PDF Chat Long-lasting severe immune dysfunction in Ebola virus disease survivors 2020 Aurélie Wiedemann
Emile Foucat
Hakim Hocini
Cécile Lefebvre
Boris P. Hejblum
Mélany Durand
Miriam Krüger
Alpha Kabinet Keïta
Ahidjo Ayouba
Stéphane Mély
1
+ PDF Chat Ebola Virus Disease Survivors Show More Efficient Antibody Immunity than Vaccinees Despite Similar Levels of Circulating Immunoglobulins 2020 Till Koch
Monika Rottstegge
Paula Ruibal
Sergio Gómez‐Medina
Emily V. Nelson
Beatriz Escudero-Pérez
Matthias Pillny
My Linh Ly
Fara Raymond Koundouno
Joseph Akoi Boré
1
+ PDF Chat Understanding Long-term Evolution and Predictors of Sequelae of Ebola Virus Disease Survivors in Guinea: A 48-Month Prospective, Longitudinal Cohort Study (PostEboGui) 2021 Mamadou Saliou Kalifa Diallo
Abdoulaye Touré
Mamadou Sow
Cécé Kpamou
Alpha Kabinet Keïta
Bernard Taverne
Martine Peeters
Philippe Msellati
Thierno Alimou Barry
Jean-François Étard
1
+ PDF Chat Temporal evolution of the humoral antibody response after Ebola virus disease in Guinea: a 60-month observational prospective cohort study 2021 Mamadou Saliou Kalifa Diallo
Ahidjo Ayouba
Alpha Kabinet Keïta
Guillaume Thaurignac
Mamadou Sow
Cécé Kpamou
Thierno Alimou Barry
Philippe Msellati
Jean-François Étard
Martine Peeters
1
+ Development of the PREDS score to predict in-hospital mortality of patients with Ebola virus disease under advanced supportive care: Results from the EVISTA cohort in the Democratic Republic of the Congo 2022 Marie Jaspard
Sabue Mulangu
Sylvain Juchet
Béatrice Serra
Ibrahim Dicko
Hans-Joeg Lang
Baweye Mayoum Baka
Gaston Musemakweli Komanda
Jeremie Muhindo Katsavara
Patricia Kabuni
1
+ PDF Chat Randomized Trial of Vaccines for Zaire Ebola Virus Disease 2022 Mark Kieh
Laura Richert
Abdoul Habib Béavogui
Birgit Grund
Bailah Leigh
Éric D’Ortenzio
Seydou Doumbia
Edouard Lhomme
Samba O. Sow
Renaud Vatrinet
1
+ PDF Chat Persistence of immunological memory as a potential correlate of long-term, vaccine-induced protection against Ebola virus disease in humans 2023 Chelsea McLean
Karin Dijkman
Auguste Gaddah
Babajide Keshinro
Michael Katwere
Macaya Douoguih
Cynthia Robinson
Laura Solforosi
Dominika N. Czapska-Casey
Liesbeth Dekking
1
+ PDF Chat Antibody responses to recombinant vesicular stomatitis virus-Zaire Ebolavirus vaccination for Ebola virus disease across doses and continents: 5-year durability 2023 Angela Huttner
Sélidji Todagbé Agnandji
Olivier Engler
Jay W. Hooper
Steve Kwilas
Keersten M. Ricks
Tamara L. Clements
Hulda R. Jónsdóttir
Sravya Sowdamini Nakka
Sylvia Rothenberger
1
+ Case fatality risk among individuals vaccinated with rVSVΔG-ZEBOV-GP: a retrospective cohort analysis of patients with confirmed Ebola virus disease in the Democratic Republic of the Congo 2024 Rebecca M. Coulborn
Mathieu Bastard
Nicolas Peyraud
Etienne Gignoux
Francisco J. Luquero
Bérengère Guai
Stéphane Hans Bateyi Mustafa
Elisabeth Mukamba Musenga
Steve Ahuka‐Mundeke
1